Log In
person
Daiichi Sankyo Company Ltd
DSNKY
summarize
3 total product lines
calendar_month
Revenue as of 03/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (JPY) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (JPY) | Percentage |
| Pharmaceuticals |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
952.05B | 91.11% |
| Pharmaceuticals |
Over-the-Counter Pharmaceuticals
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
64.53B | 6.18% |
| Pharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
28.31B | 2.71% |
| keyboard_arrow_down |
Pharmaceuticals
Branded Pharmaceuticals
|
952.05B | 91.11% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Pharmaceuticals
Over-the-Counter Pharmaceuticals
|
64.53B | 6.18% |
| keyboard_arrow_right |
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
||
| keyboard_arrow_down |
Pharmaceuticals
Pre-Revenue Pharmaceuticals
|
28.31B | 2.71% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||